Lexeo Therapeutics (LXEO) & Its Peers Head-To-Head Survey
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) is one of 287 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its rivals? We will compare Lexeo Therapeutics to related businesses based on the strength of its profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Analyst Recommendations This […]
More Stories
Oak Woods Acquisition Co. (NASDAQ:OAKUW) Sees Significant Decline in Short Interest
Oak Woods Acquisition Co. (NASDAQ:OAKUW – Get Free Report) was the recipient of a significant drop in short interest in...
PIMCO Municipal Income Fund III (NYSE:PMX) Short Interest Down 24.4% in October
PIMCO Municipal Income Fund III (NYSE:PMX – Get Free Report) was the recipient of a large decrease in short interest...
Enstar Group Limited (NASDAQ:ESGRO) Short Interest Update
Enstar Group Limited (NASDAQ:ESGRO – Get Free Report) saw a large drop in short interest during the month of October....
Crescent Energy (NYSE:CRGY) Short Interest Down 10.7% in October
Crescent Energy (NYSE:CRGY – Get Free Report) was the target of a significant drop in short interest in October. As...
Short Interest in East West Bancorp, Inc. (NASDAQ:EWBC) Decreases By 10.6%
East West Bancorp, Inc. (NASDAQ:EWBC – Get Free Report) saw a large decline in short interest during the month of...
Bilibili (NASDAQ:BILI) Announces Earnings Results
Bilibili (NASDAQ:BILI – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.57 earnings per share...